Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Equity-to-Asset : 0.77 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Chongqing Genrix Biopharmaceutical Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Chongqing Genrix Biopharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥2,658.79 Mil. Chongqing Genrix Biopharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was ¥3,451.40 Mil. Therefore, Chongqing Genrix Biopharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.77.

The historical rank and industry rank for Chongqing Genrix Biopharmaceutical Co's Equity-to-Asset or its related term are showing as below:

SHSE:688443' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.75 Med: 0.16 Max: 0.79
Current: 0.77

During the past 5 years, the highest Equity to Asset Ratio of Chongqing Genrix Biopharmaceutical Co was 0.79. The lowest was -0.75. And the median was 0.16.

SHSE:688443's Equity-to-Asset is ranked better than
62.74% of 1554 companies
in the Biotechnology industry
Industry Median: 0.67 vs SHSE:688443: 0.77

Chongqing Genrix Biopharmaceutical Co Equity-to-Asset Historical Data

The historical data trend for Chongqing Genrix Biopharmaceutical Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Genrix Biopharmaceutical Co Equity-to-Asset Chart

Chongqing Genrix Biopharmaceutical Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

-0.58

-0.75

0.31

0.03

0.78

Chongqing Genrix Biopharmaceutical Co Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Equity-to-Asset	Get a 7-Day Free Trial								-0.09	0.75	0.79	0.78	0.77

Competitive Comparison of Chongqing Genrix Biopharmaceutical Co's Equity-to-Asset

For the Biotechnology subindustry, Chongqing Genrix Biopharmaceutical Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chongqing Genrix Biopharmaceutical Co's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chongqing Genrix Biopharmaceutical Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Chongqing Genrix Biopharmaceutical Co's Equity-to-Asset falls into.

Chongqing Genrix Biopharmaceutical Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Chongqing Genrix Biopharmaceutical Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	2784.232	/	3594.597
	=	0.77

Chongqing Genrix Biopharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	2658.792	/	3451.396
	=	0.77

Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Chongqing Genrix Biopharmaceutical Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Chongqing Genrix Biopharmaceutical Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chongqing Genrix Biopharmaceutical Co Ltd (SHSE:688443) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 699, Maliu Avenue, Area A, Building 2, International Bio City, Banan, Chongqing, CHN, 401338

Website

http://www.genrixbio.com

Chongqing Genrix Biopharmaceutical Co Ltd is engaged in the research & development, production and sales of antibody drugs. The company has a total of more than ten products under research covering three major therapeutic areas. The progress of core products is leading, and some product pipelines are as follows; autoimmune disease, infectious disease, and tumor. Its product Xeligekimab injection (Xeligekimab) is a recombinant fully human anti-IL-17A monoclonal antibody independently developed by the company, which has been accepted by the National Medical Products Administration (NMPA) for new drug marketing applications.

Executives

Jiang Ren Sheng

Director

Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Headlines

No Headlines